HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms

M Navab, ST Reddy, BJ Van Lenten… - Nature Reviews …, 2011 - nature.com
The lipoprotein HDL has two important roles: first, it promotes reverse cholesterol transport,
and second, it modulates inflammation. Epidemiological studies show that HDL-cholesterol …

[HTML][HTML] Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit

F Brites, M Martin, I Guillas, A Kontush - BBA clinical, 2017 - Elsevier
Uptake of low-density lipoprotein (LDL) particles by macrophages represents a key step in
the development of atherosclerotic plaques, leading to the foam cell formation. Chemical …

[HTML][HTML] Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation

BJ Bennett, TQ de Aguiar Vallim, Z Wang, DM Shih… - Cell metabolism, 2013 - cell.com
Circulating trimethylamine-N-oxide (TMAO) levels are strongly associated with
atherosclerosis. We now examine genetic, dietary, and hormonal factors regulating TMAO …

[HTML][HTML] Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

C Besler, K Heinrich, L Rohrer… - The Journal of …, 2011 - Am Soc Clin Investig
HDL cholesterol activates endothelial cell production of the atheroprotective signaling
molecule NO, and it promotes endothelial repair. In this issue of the JCI, Besler et al. provide …

Paraoxonase-1 is a major determinant of clopidogrel efficacy

HJ Bouman, E Schömig, JW Van Werkum, J Velder… - Nature medicine, 2011 - nature.com
Clinical efficacy of the antiplatelet drug clopidogrel is hampered by its variable
biotransformation into the active metabolite,. The variability in the clinical response to …

Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles

M Mackness, B Mackness - Gene, 2015 - Elsevier
Human PON1 is a HDL-associated lipolactonase capable of preventing LDL and cell
membrane oxidation and is therefore considered to be atheroprotective. PON1 contributes to …

An abundant dysfunctional apolipoprotein A1 in human atheroma

Y Huang, JA DiDonato, BS Levison, D Schmitt, L Li… - Nature medicine, 2014 - nature.com
Recent studies have indicated that high-density lipoproteins (HDLs) and their major
structural protein, apolipoprotein A1 (apoA1), recovered from human atheroma are …

New gene functions in megakaryopoiesis and platelet formation

C Gieger, A Radhakrishnan, A Cvejic, W Tang, E Porcu… - Nature, 2011 - nature.com
Platelets are the second most abundant cell type in blood and are essential for maintaining
haemostasis. Their count and volume are tightly controlled within narrow physiological …

Lead and cadmium as cardiovascular risk factors: the burden of proof has been met

GA Lamas, F Ujueta, A Navas‐Acien - Journal of the American …, 2021 - Am Heart Assoc
Globally, cardiovascular disease (CVD) is the leading cause of mortality, taking an estimated
17.9 million lives annually. Myocardial infarction and stroke account for 80% of these deaths …

The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects*♦

M Zamanian-Daryoush, D Lindner, TC Tallant… - Journal of biological …, 2013 - ASBMB
Here, we show that apolipoprotein A1 (apoA1), the major protein component of high density
lipoprotein (HDL), through both innate and adaptive immune processes, potently …